APA (7th ed.) Citation

SU, S., M, C., JJ, M., K, A., SK, W., N, K., . . . RC, W. (2025). Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells. Nature protocols, 20(10), 2735. https://doi.org/10.1038/s41596-025-01154-8

Chicago Style (17th ed.) Citation

SU, Sahu, et al. "Peptide-enabled Ribonucleoprotein Delivery for CRISPR Engineering (PERC) in Primary Human Immune Cells and Hematopoietic Stem Cells." Nature Protocols 20, no. 10 (2025): 2735. https://doi.org/10.1038/s41596-025-01154-8.

MLA (9th ed.) Citation

SU, Sahu, et al. "Peptide-enabled Ribonucleoprotein Delivery for CRISPR Engineering (PERC) in Primary Human Immune Cells and Hematopoietic Stem Cells." Nature Protocols, vol. 20, no. 10, 2025, p. 2735, https://doi.org/10.1038/s41596-025-01154-8.